C. diff carriers without symptoms fuel most transmission in cancer wards, model finds

by Tracey Peake, North Carolina State University

edited by Robert Egan

Robert Egan

Senior Editor

Meet our editorial team
Behind our editorial process
Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source

In a new study, researchers modeled the transmission of Clostridioides difficile (C. diff) infections among patients in hospital cancer units. They found that most new infections were introduced by patients who were infected but not symptomatic at the time of admission, rather than by patients who were infected and symptomatic. The model provides a clearer picture of C. diff transmission events in oncology wards and could help inform protocols aimed at preventing future disease transmission in a highly susceptible population.

Cancer treatments, while increasingly effective, leave their recipients immunocompromised and at greater risk of contracting infections than the general population. Hospital-acquired infections can cause severe complications in cancer patients, and C. diff is one of the most common.

"Physicians have singled out antimicrobial resistance as a big issue for improvement in cancer patients," says Cristina Lanzas, professor of infectious disease at North Carolina State University's College of Veterinary Medicine and corresponding author of the research.

"The cancer treatments are improved, but the secondary infections patients get because they are so immunocompromised can be fatal. We decided to look at how C. diff infections were transmitted in oncology wards."

Tracing infections beyond visible symptoms

Generally speaking, clinicians test patients for C. diff only when they have clinical signs; however, patients can also carry this pathogen in the gut without symptoms and may contribute to its transmission.

The researchers combined six months of active patient surveillance (testing patients for C. diff regardless of clinical signs) with a simulation model of every room, patient and staff connection in two cancer units. The data were provided by collaborators at Washington University School of Medicine.

"Testing data only provides a snapshot—are you positive or negative on a given day and time—but transmission events are invisible," Lanzas says. "We developed models that traced potential transmission routes and then looked at each model's ability to replicate actual infection data. Then we chose the model that aligned best with the data we had."

Asymptomatic patients drove most transmission

According to the model, testing alone captures only 23% of patients carrying C. diff.

The modeling also revealed that patients with active C. diff infections were not the main source of new colonization. Rather, asymptomatic colonized (AC) patients—people who carry C. diff but don't have clinical signs—were responsible for 92% of transmissions that resulted in new colonizations.

Models could guide ward infection protocols

The researchers hope that their model could be applied to different pathogens to help clinicians and hospitals identify contact points where infection risks are increased.

"The issue of people carrying pathogens without knowing about it is very common with all antimicrobial-resistant pathogens—we can really be our own worst enemies," Lanzas says. "But by modeling these events, we can make the invisible visible, and perhaps that can lead to new protocols for patients coming into these wards."

The study appears in Infection Control and Hospital Epidemiology.

Other NC State collaborators are Ph.D. candidate Savannah Curtis and postdoctoral researcher Sankalp Arya. Tiffany Hink, Kimberly Reske, Emily Struttmann, Zainab Hassan Iqbal, Candice Cass, Margaret Olsen, Carey-Ann Burnham and Erik R. Dubberke from Washington University School of Medicine; Mary Lee of Vanderbilt University Medical Center; and Suzanne Lenhart from the University of Tennessee also contributed to the work.

Publication details

Savannah Curtis et al, Quantifying the contributions of asymptomatic and symptomatic colonized patients to Clostridioides difficile acquisition in oncological units, Infection Control & Hospital Epidemiology (2026). DOI: 10.1017/ice.2026.10557

Journal information: Infection Control and Hospital Epidemiology

Key medical concepts

C. diff InfectionsClostridioides difficile

Clinical categories

Infectious diseasesOncologyCommon illnesses & PreventionHospital medicine Provided by North Carolina State University Who's behind this story?

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: C. diff carriers without symptoms fuel most transmission in cancer wards, model finds (2026, October 5) retrieved 5 October 2026 from https://medicalxpress.com/news/2026-10-diff-carriers-symptoms-fuel-transmission.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.